Reimbursed with a limitationOriginator productATC C01EB18

Ranexa

Ranexa is an originator product from A. Menarini GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 66.80 to CHF 98.80 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
A. Menarini GmbH
ATC code
C01EB18
IT group
02.99 Varia
Active substances
Ranolazinum
Preparation type
Originator product
On the SL since
01/10/2010
Last price change
01/12/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Ranexa Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Ret Tabl 375 mg60 StkCHF 46.31CHF 66.8001/10/2010B7680605330028
Ret Tabl 375 mg100 StkCHF 75.73CHF 98.8001/10/2010B7680605330035
Ret Tabl 500 mg60 StkCHF 46.31CHF 66.8001/10/2010B7680605330059
Ret Tabl 500 mg100 StkCHF 75.73CHF 98.8001/10/2010B7680605330066
Ret Tabl 750 mg60 StkCHF 46.31CHF 66.8001/10/2010B7680605330080
Ret Tabl 750 mg100 StkCHF 75.73CHF 98.8001/10/2010B7680605330097

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/10/2010

Als Ergänzungstherapie für Patienten, welche an den Symptomen einer chronisch stabilen Angina pectoris leiden, wenn andere antianginöse Mittel (z.B. Betablocker, Calciumantagonisten, Nitrate) nicht genügend wirksam sind oder nicht eingesetzt werden können und wenn eine perkutane Koronarintervention nicht angezeigt ist.

FAQ

Is Ranexa covered by Swiss health insurance?

Yes, but only under conditions. Ranexa is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Ranexa cost in Switzerland?

The public price is the maximum price set by the FOPH and for Ranexa ranges from CHF 66.80 to CHF 98.80 per pack. The ex-factory price ranges from CHF 46.31 to CHF 75.73. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com